If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,292.00
Bid: 1,286.00
Ask: 1,292.00
Change: -6.00 (-0.46%)
Spread: 6.00 (0.467%)
Open: 1,272.00
High: 1,292.00
Low: 1,272.00
Prev. Close: 1,298.00
VCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

14 Jun 2023 07:00

RNS Number : 6184C
Victrex PLC
14 June 2023
 
 

14 June 2023

Victrex plc - Trading update

Victrex plc is an innovative world leader in high performance polymer solutions, delivering sustainable products which support CO2 reduction and bring environmental and societal benefit in multiple end-markets. Today's trading update covers the period ending 31 May 2023.

Year-to-date (YTD) Group volume & revenue

At the Group's interim results we signalled that, in line with the wider Chemical sector, ongoing macro-economic weakness and industrial customer destocking were impacting performance in several end markets. During the first half, Group volumes declined by 14%.

Whilst the Group remains ready to benefit from a macro-economic recovery, latest indicators suggest these current headwinds will now continue over the summer and at least until the end of FY 2023 in September.

Despite good progress in Medical, ongoing industrial headwinds mean YTD Group volumes are now tracking in excess of 20% down, compared to the record prior year. YTD Group revenue is tracking down by a mid-single digit percentage rate. If current run-rates continue, full year revenue would be down between 6%-10%.

For Q3 as a whole, we anticipate volumes will be approximately 800 tonnes (Q3 2022: 1,323 tonnes).

Outlook

In our Outlook at the interim results stage, we signalled that delivering full-year adjusted (pre-exceptional) profit before tax (PBT) in line with expectations assumed a step up in demand during the latter part of the second half, driven by macro-economic conditions.

Whilst we are seeing progress on gross margin, driven by pricing, sales mix, currency and easing energy costs, Group adjusted PBT to 31 May 2023 was approximately £53m. With no step up in demand going into the final quarter currently visible, and the resulting lower industrial revenue expectations, our full year adjusted PBT is now expected to be between £80m-£85m.  

Victrex will report its Q3 Interim Management Statement on Thursday 6 July 2023.

 

Analyst & investor conference call:

A conference call with management will take place this morning, 14 June 2023, at 08.00am BST. The call can be accessed via the following link:

 

https://services.choruscall.za.com/DiamondPassRegistration/register?confirmationNumber=2616372&linkSecurityString=6aee7987c

 

Inside information:

This announcement contains inside information. The person responsible for making this announcement is Jane Brisley, General Counsel & Company Secretary.

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations, Corporate Communications & ESG +44 (0) 7809 595831

Jakob Sigurdsson, Chief Executive +44 (0) 1253 897700

Ian Melling, Chief Financial Officer +44 (0) 1253 897700

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy & Industrial, Electronics and Medical. Every day, millions of people rely on products or applications which contain our sustainable materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 40 years' experience, we are moving beyond the polymer into semi-finished and finished products which shape future performance for our customers and our markets, provide environmental and societal benefit for customers and drive value for our shareholders. Find out more at www.victrexplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUAAQUPWPGW
Date   Source Headline
28th Feb 202210:46 amRNSTotal Voting Rights
22nd Feb 20221:14 pmRNSDirector/PDMR Shareholding
17th Feb 202212:30 pmRNSDirector/PDMR Shareholding
15th Feb 202212:12 pmRNSHolding(s) in Company
11th Feb 202212:21 pmRNSResult of AGM
11th Feb 20227:00 amRNSAGM & Q1 Interim Management Statement
10th Feb 20222:06 pmRNSDirector/PDMR Shareholding
10th Feb 202210:15 amRNSHolding(s) in Company
31st Jan 202210:23 amRNSTotal Voting Rights
28th Jan 20223:23 pmRNSHolding(s) in Company
24th Jan 20223:54 pmRNSHolding(s) in Company
20th Jan 20229:21 amRNSAdditional Listing
18th Jan 20223:11 pmRNSDirector/PDMR Shareholding
6th Jan 20222:14 pmRNSAnnual Report and Accounts
6th Jan 20229:53 amRNSDirector/PDMR Shareholding
31st Dec 20219:00 amRNSTotal Voting Rights
17th Dec 20213:59 pmRNSHolding(s) in Company
17th Dec 202112:01 pmRNSDirector/PDMR Shareholding
16th Dec 20211:06 pmRNSDirector/PDMR Shareholding
13th Dec 202111:20 amRNSDirector/PDMR Shareholding
6th Dec 20217:00 amRNSVictrex plc – Preliminary Results 2021
1st Dec 20213:48 pmRNSBlock listing Interim Review
30th Nov 202111:39 amRNSTotal Voting Rights
18th Nov 20212:12 pmRNSDirector Declaration
17th Nov 202112:17 pmRNSDirector/PDMR Shareholding
9th Nov 20211:51 pmRNSDirector Declaration - Replacement
9th Nov 20219:00 amRNSDirector Declaration
29th Oct 20219:25 amRNSTotal Voting Rights
21st Oct 20217:00 amRNSVictrex signs up to SBTi
19th Oct 202111:13 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSDirectorate Change
14th Oct 20217:00 amRNSTechnipFMC to acquire Victrex’s Magma equity
30th Sep 20212:22 pmRNSTotal Voting Rights
20th Sep 20217:00 amRNSChair-designate appointment
17th Sep 202110:51 amRNSDirector/PDMR Shareholding
31st Aug 202110:23 amRNSTotal Voting Rights
18th Aug 20214:11 pmRNSDirector/PDMR Shareholding
30th Jul 202112:18 pmRNSTotal Voting Rights
19th Jul 202110:21 amRNSDirector/PDMR Shareholding
9th Jul 20217:00 amRNSVictrex Q3 Interim Management Statement
30th Jun 202110:23 amRNSTotal Voting Rights
17th Jun 202111:29 amRNSDirector/PDMR Shareholding
16th Jun 20212:13 pmRNSAdditional Listing
2nd Jun 202111:10 amRNSDirector/PDMR Shareholding
1st Jun 20219:35 amRNSBlock listing Interim Review
28th May 20211:09 pmRNSTotal Voting Rights
18th May 20214:50 pmRNSDirector Declaration
18th May 202110:32 amRNSDirector/PDMR Shareholding
17th May 202110:56 amRNSDirector/PDMR Shareholding
13th May 202110:08 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.